rolipram has been researched along with Hepatitis, Animal in 1 studies
Hepatitis, Animal: INFLAMMATION of the LIVER in non-human animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taguchi, I | 1 |
| Oka, K | 1 |
| Kitamura, K | 1 |
| Sugiura, M | 1 |
| Oku, A | 1 |
| Matsumoto, M | 1 |
1 other study available for rolipram and Hepatitis, Animal
| Article | Year |
|---|---|
Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis.
Topics: Animals; Bucladesine; Hepatitis, Animal; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Phosp | 1999 |